X-twitter Youtube Instagram Video

DrugCard

DrugCard is an AI pharmacovigilance platform built for pharmaceutical companies and CROs. It automates medical literature screening across 100 languages to detect adverse events. While it reduces manual reading time by up to 90 percent, human oversight remains mandatory to validate AI-detected safety signals before regulatory submission.
  • Pricing: Custom Pricing
Website

What is DrugCard?

Pharmacovigilance teams expect AI to completely replace manual literature screening. DrugCard delivers a massive reduction in reading time, but it still requires human experts to validate the final safety signals. Users get an automated pipeline that scans global databases, translates text, and flags potential adverse events.

Developed by DrugCard OU, this platform targets pharmaceutical companies and clinical research organizations. It solves the specific problem of regulatory compliance in medical literature monitoring. The software scans sources like PubMed and Embase to ensure teams meet EMA and FDA reporting standards.

  • Primary Use Case: Automating medical literature screening for adverse event detection.
  • Ideal For: Pharmacovigilance teams at mid-to-large pharmaceutical companies.
  • Pricing: Starts at Custom Pricing (Enterprise model) with a 2-week free trial.

Key Features and How DrugCard Works

Automated Literature Monitoring

  • Global Database Scanning: The system monitors sources like PubMed 24/7. It only covers indexed databases, so highly obscure local print journals require manual entry.
  • Custom Search Queries: Users build filters using Boolean logic and MeSH terms. Complex queries can sometimes return high volumes of false positives.

Multilingual Processing

  • 100+ Language Translation: The NLP engine translates foreign medical texts into English. The translation accuracy drops slightly for regional medical slang (which often varies by country).
  • Local Journal Tracking: It monitors regional regulatory websites. You must configure specific target URLs during onboarding.

Adverse Event Detection

  • AI Signal Extraction: The platform identifies individual case safety reports from unstructured text. Human reviewers must still approve every flagged event.
  • Duplicate Detection: It flags redundant reports across different sources. The system occasionally struggles if authors use vastly different phrasing for the same case.

Regulatory Compliance Tools

  • Audit Trails: The software logs every screening activity with a timestamp. You cannot edit these logs once the system creates them.
  • Standardized Exports: Users generate reports in PDF, Excel, and XML formats. XML exports require strict mapping to match your specific safety database version.

DrugCard Pros and Cons

Pros

  • Reduces manual literature screening time by up to 90 percent for pharmacovigilance teams.
  • Processes medical text in over 100 languages, cutting external translation costs.
  • Aligns directly with GVP Module VI and E2B(R3) standards for EMA and FDA compliance.
  • Maintains a strict, unalterable audit trail for regulatory inspections.
  • Cloud architecture allows teams to complete onboarding and setup in just a few days.

Cons

  • Enterprise pricing creates a high barrier to entry for small biotech startups.
  • Human oversight remains mandatory to confirm AI-detected signals before reporting.
  • The platform focuses entirely on pharmacovigilance, making it useless for general academic research.

Who Should Use DrugCard?

  • Mid-to-Large Pharma Companies: Teams managing high volumes of global literature need this automation to stay compliant.
  • Clinical Research Organizations: CROs handling safety monitoring for multiple sponsors benefit from the collaborative workspace.
  • Global Safety Officers: Professionals who need to monitor local medical journals across different languages without hiring translators.
  • Not for Academic Researchers: University researchers looking for general literature review tools will find this software too expensive and narrowly focused.

DrugCard Pricing and Plans

DrugCard operates strictly on a custom enterprise pricing model.

The company does not publish standard rates on its website.

The platform offers a 2-week free trial. This is a genuine trial that provides full access to the automated monitoring and NLP features. Teams can test the system against their own search queries.

The Custom Enterprise Plan includes all core features. Users get AI literature screening, adverse event management, and multilingual translation. Pricing scales based on the volume of literature monitored and the number of user seats required.

How DrugCard Compares to Alternatives

PubHive offers a broader suite of scientific literature tools. Similar to DrugCard, it automates pharmacovigilance screening. Unlike DrugCard, PubHive includes modules for systematic literature reviews and real-world evidence tracking. PubHive appeals more to teams needing a single platform for multiple research departments.

Dialog Solutions provides extensive access to premium scientific databases. DrugCard focuses heavily on AI extraction and translation. Dialog Solutions excels in raw content access and complex search building. Teams that prioritize access to paywalled journals often prefer Dialog Solutions.

Verdict: Best for Global Pharmacovigilance Teams

DrugCard delivers massive value to global safety teams drowning in manual literature reviews. The ability to scan and translate 100 languages automatically removes a major compliance bottleneck. Mid-sized and large pharmaceutical companies will easily justify the custom pricing through time saved.

Small biotech startups with limited budgets should look elsewhere. The enterprise pricing model makes it difficult for early-stage companies to adopt. If you need a more generalized research tool, PubHive is a better alternative. DrugCard remains a highly specialized, highly effective tool for strict regulatory safety monitoring.

Core Capabilities

Key features that define this tool.

  • Automated Literature Monitoring: Scans global databases 24/7 for safety data. It only monitors indexed digital sources, leaving out obscure print-only journals.
  • Multilingual NLP: Translates medical text across 100 languages. Accuracy drops slightly when processing highly specific regional medical slang.
  • Adverse Event Detection: Identifies potential safety signals from unstructured text. Human reviewers must still manually validate every flagged event.
  • Duplicate Detection: Flags redundant reports across different sources. The system occasionally misses duplicates if authors use vastly different phrasing.
  • Audit Trail: Logs a timestamped history of all screening activities. Users cannot edit or append notes to these automated logs.
  • Collaborative Workspace: Allows multiple officers to review findings simultaneously. It lacks granular permission settings for temporary external contractors.
  • Custom Search Queries: Supports Boolean logic and MeSH terms for precise filtering. Overly complex queries often return a high volume of false positives.
  • Export Formats: Generates reports in PDF, Excel, and XML formats. XML exports require strict manual mapping to match specific safety database versions.

Pricing Plans

  • Free Trial: $0/mo – 2-week full access to experience platform benefits and automated monitoring.
  • Custom Enterprise Plan: Custom Pricing – Includes AI-powered literature screening, regulatory intelligence, adverse event management, and 24/7 automated monitoring across 100+ languages.

Frequently Asked Questions

  • Q: Is DrugCard compliant with GVP Module VI? Yes, DrugCard aligns directly with GVP Module VI requirements. It maintains strict audit trails and generates standardized reports for regulatory inspections.
  • Q: How does DrugCard handle local medical journals? The platform monitors regional regulatory websites and local journals using automated translation. Users must configure specific target URLs during the initial setup process.
  • Q: Can DrugCard integrate with Argus or ArisGlobal? DrugCard generates E2B(R3) compliant XML exports. Teams can import these standardized files directly into safety databases like Oracle Argus or ArisGlobal LifeSphere.
  • Q: What languages does DrugCard support for literature screening? The software processes and translates medical text in over 100 languages. This global coverage reduces the need for external local translation services.
  • Q: How does DrugCard ensure data security and GDPR compliance? DrugCard uses a secure cloud architecture to protect sensitive pharmacovigilance data. The company implements strict access controls and maintains full GDPR compliance for European users.

Tool Information

Developer:

DrugCard OU

Release Year:

2019

Platform:

Web-based

Rating:

4.5